Abstract

Background
In erythroblasts, the CoREST repressor complex is recruited to target promoters by the transcription factor Gfi1b, leading to repression of genes mainly involved in erythroid differentiation. Hmg20b is a subunit of CoREST, but its role in erythropoiesis has not been established yet.
Design and Methods
To study the role of Hmg20b in erythropoiesis, we performed knockdown experiments in a differentiation-competent mouse fetal liver cell line, and in primary mouse fetal liver cells. The effects on globin gene expression were determined. We used microarrays to investigate global gene expression changes induced by Hmg20b knockdown. Functional analysis was carried out on Hrasls3, an Hmg20b target gene.
Results
We show that Hmg20b depletion induces spontaneous differentiation. To identify the target genes of Hmg20b, microarray analysis was performed on Hmg20b knockdown cells and controls. In line with its association to the CoREST complex, we found that 85% (527 out of 620) of the deregulated genes are upregulated when Hmg20b levels are reduced. Among the few downregulated genes was Gfi1b, a known repressor of erythroid differentiation. One of the consistently upregulated targets were embryonic β-like globins and the phospholipase HRAS-like suppressor 3 (Hrasls3). We show that Hrasls3 expression is induced during erythroid differentiation and that knockdown of Hrasls3 inhibits terminal differentiation of proerythroblasts.
Introduction
Erythropoiesis is a multi-step developmental process that commences with pluripotent hematopoietic stem cells in the bone marrow and culminates in the release of enucleated and hemoglobinized reticulocytes in the circulation (1) . Erythroid progenitors undergo massive expansion and pass through several differentiation steps including the morphologically recognizable proerythroblast, basophilic and orthochromatic erythroblast stages (2) . These final steps involve a series of three to five differentiation-specific cell divisions before the cells arrest in G1, enucleate and undergo terminal maturation to erythrocytes (3) .
Studies on erythropoiesis have revealed the basics of tissue-specific gene regulation, in which transcription factors and chromatin modifying complexes play a major role (4) . CoREST (corepressor of repressor element-1-silencing transcription factor) is a chromatin-modifying complex that was first described as a regulator of neuronal gene expression, playing a crucial role in neuronal differentiation (5) . In these cells, the CoREST complex is recruited by REST (RE1-silencing transcription factor) that recognizes the 21-nucleotide RE-1 sequence in the promoter of more than 1700 different target genes in human and mouse (6) . The CoREST complex is composed of multiple subunits, including RCOR1, lysine-specific demethylase I (Lsd1), histone deacetylases 1/2 (HDACs 1/2) and two very similar proteins from the High Mobility Group (HMG) family, Hmg20a and Hmg20b (7) . In erythroblasts the transcriptional regulator Gfi1b recruits the CoREST complex to the majority of its target gene promoters in vivo. Similar to neuronal cells, inhibition of CoREST disturbs differentiation of erythroid progenitors, as well as megakaryocytic and granulocytic precursors (8) .
Several studies have shown the function of various CoREST complex subunits in erythropoiesis (9-10) , but the role of Hmg20a and Hmg20b in erythropoiesis has so far not been established. It is believed that Hmg20b-containing CoREST complexes mediate chromatin remodelling and repression of specific genes involved in neuronal differentiation through modulation of chromatin structure (11) (12) . In erythroblasts the transcriptional regulator Gfi1b recognizes TAAATCAC(A/T)GCA (13) (14) and recruits the CoREST complex to the majority of its target gene promoters in vivo. Inhibition of Gfi1b and the CoREST subunit Lsd1 disturbs differentiation of erythroid progenitors, as well as megakaryocytic and granulocytic precursors (8, 15) .
Hmg20b is an HMG domain protein with the ability of non-specific DNA binding. It is expressed in various tissues with relative high levels in the brain (16) , and is classified in a new group of HMG proteins due to the presence of a kinesin-like coiled-coil domain with no known function (17) . The only known protein with relatively high homology to Hmg20b is BAF-57 (BRG1-associated factor 57) (16) . BAF-57 is part of the SWI/SNF remodelling complex in association with the RCOR1 protein and plays a crucial role in cell proliferation and cell cycle progression (18) .
To investigate the role of Hmg20b during erythroid differentiation, we employed primary proerythoblasts from mouse fetal liver, as well as I/11 cells, a cell line derived from p53 knockout mouse fetal liver (19) . These cells can be expanded in the presence of erythropoietin (EPO), stem cell factor (SCF) and dexamethasone (20) . In the absence of SCF and dexamethasone, the majority of the cells hemoglobinize and enucleate within three days. This differentiation process requires the presence of EPO and transferrin (21) .
Here, we studied the role of Hmg20b protein in the balance of erythroid proliferation and differentiation by performing knockdown experiments. We used whole genome expression profiling to further investigate the role of Hmg20b in maintaining this balance, and we assessed the impact of Hmg20b knockdown on globin gene expression.
Design and Methods
Cell culture
I/11 erythroid progenitors and primary mouse fetal liver cells were cultured as described (19) .
Primary mouse fetal liver cells were collected on embryonic day 12.5 and expanded for three days before lentiviral transduction according to an established protocol (21) . To induce differentiation, proliferating erythroblasts were washed in ice-cold PBS and reseeded at 1-1.5x10
6 cells/ml in StemPro (Invitrogen, Carlsbad, USA) supplemented with EPO (10U/ml, Janssen-Cilag BV, Tilburg, NL) and holo-transferrin (1mg/ml; SCIPAC Ltd, Sittingbourne, UK). Differentiating I/11 cells were maintained at 2-3x10 6 cells/ml. To determine the morphological changes, cells were cytospun and stained with histological dyes (Diff-Quick staining set; Medion Diagnostics International Inc, Miami, USA) and neutral benzidine (22) . To measure cell size distribution, a CASY instrument (Roche Innovatis AG, Bielefeld, D) was used. Hemoglobin assays were performed according to a published protocol (23) . All experiments involving mice were approved by the Erasmus MC Animal Ethics Committee.
Biotinylation and tagging and protemics analysis
Bio-HA-HMG20B was cloned into a modified 5pRRLsin.sPPT.CMV.GFP.Wpre lentiviral vector (24) . BirA-expressing I/11 cells were transduced with Bio-HA-HMG20B and Bio-HA lentiviruses.
The transduced cells were selected using puromycin (1µg/ml) and were expanded in culture.
Sample preparation and mass spectrometry analyses were carried out as described previously (25) .
Virus transduction
Short hairpin constructs were from the TRC library (26); Sigma Aldrich, St. Louis, USA). For knockdown of Hmg20b, TRCN0000081665 (Hmg20b shRNA#1), and TRCN0000081664 (Hmg20b shRNA#2) were used. For Hrasls3 knockdown TRCN0000077660 (Hrasls3 shRNA#1), and TRCN0000077662 (Hrasls3 shRNA#2) were used. SHC002 was employed as a control.
Lentiviruses were produced by transiently transfecting 293T cells with helper plasmids, the viruscontaining supernatants were collected for three days and concentrated by ultracentrifugation (27) .
Five days after transduction, the cells were collected and whole cell lysates prepared for western blotting. RNA extraction was carried out for Quantitative Real-Time PCR (QRT-PCR) analysis. For differentiation, cells at day five after transduction were washed twice with PBS and cultured in differentiation medium for four days. 
Western blotting and antibodies
QRT-PCR analysis and statistical analysis
RNA was extracted using TRI reagent (Sigma-Aldrich) in accordance with the protocol provided by the company. 2 µg of RNA was used to synthesize cDNA, using oligo dT, RNase OUT, SuperScript reverse transciptase (Invitrogen) in a total volume of 20 µl, and 0.3 µl of cDNA was used for further amplification by QRT-PCR. Amplification was performed with the primers listed in Supplementary 
Microarray analysis
RNA samples were extracted from biological triplicates using shRNA#1, control SHC002 and nontransduced I/11 cells three days after transduction. RNA samples were qualitatively controlled and microarray analysis was performed as described (28) (29) . The differentially regulated genes between control SHC002 and non-transduced I/11 cell cells were excluded from the final comparison with Hmg20b knockdown I/11 cell cells. Microarray data have been deposited in the NCBI GEO database (GSE29169).
ChIP analysis
To perform chromatin immunoprecipitation (ChIP) 2x10 7 of either 1/11 or MEL cells were crosslinked with 1% formaldehyde for 10 min. The reaction was stopped with 0.125 M glycine at room temperature and the cells were washed two times with PBS. The cells were resuspended in sonication buffer (10 mM Tris pH 8, 1 mM EDTA and 0.5 mM EGTA) and sonicated with amplitude 7 for 30 cycles (10 sec on, 45 sec off, Soniprep150, MSE, UK).
After centrifugation (10 min at 13 krpm) the supernatants were incubated overnight with Hmg20b
(14582-1-AP, Proteintech Group Inc, Chicago, USA) or Lsd1 (ab17721, Abcam, Cambridge, UK)
antibodies and Protein A Agarose/Salmon Sperm DNA beads (Millipore, Billerica, USA). Washing and elution was performed according to the protocol provided by the manufacturer (Millipore).
Results
Hmg20b is part of the CoREST complex in I/11 cells
Hmg20b has been reported as a subunit of two different complexes in HeLa cells, CoREST and BRCA2 (7). In mouse erythroleukemia (MEL) cell line Hmg20b acts as part of the CoREST complex (8) . To identify Hmg20b interaction partners in growth factor-dependent erythroid progenitors we used I/11 cells, a cell line derived from p53 knockout mouse fetal liver (19 Figure 1A -B). Protein extracts, streptavidin pulldown of Bio-HA-Hmg20b and associated proteins, and mass spectrometry analysis were performed as described (25, (30) (31) . Streptavidin pull-down of Bio-HA-Hmg20b followed by mass spectrometry analysis revealed that Hmg20b is part of the CoREST complex in proliferating and differentiating I/11 cells. Consistent with previous data (8), we also identified the transcriptional repressor protein Gfi1b in the mass spectrometry data. Very few other interacting proteins were identified, and we therefore conclude that CoREST is the major complex in which Hmg20b participates in I/11 cells ( Figure 1A -B). We also studied the expression changes of Hmg20b and Gfi1b in differentiating I/11 cells. Western blot and QRT-PCR analyses showed a modest decrease in Hmg20b and Gfi1b expression during I-11 cell differentiation ( Figure 1C -E).
Knockdown of Hmg20b induces spontaneous erythroid differentiation
To assess the role of Hmg20b in erythroid differentiation, we applied lentiviral-mediated knockdown of Hmg20b expression in I/11 cells. Western blot and QRT-PCR analysis confirmed that two independent shRNA constructs reduced Hmg20b expression to less than 20% of wild-type levels at day three after transduction ( Figure 2A-B) . Cell counting revealed a slower expansion of Hmg20b knockdown cells ( Figure 2C ). Differentiating erythroblasts go through three to five cell divisions before entering G1 arrest and terminal differentiation (3). Hmg20b depletion resulted in G1 accumulation of I/11 cells grown in expansion medium, with concomitant decrease in proliferation rate (Online Supplementary Figure 2 ). In line with reduced proliferation, differentiating cells were clearly detected by CASY cell counting profiles at day five to seven after transduction (cells <10µm; Figure 2D ). Knockdown by shRNA #1 was more efficient than that obtained with shRNA #2 with the latter resulting in the most efficient I/11 cell differentiation. This suggests that a low level of Hmg20b protein augments completion of the differentiation and enucleation process, possibly because this allows completion of the 3-5 cell divisions required for normal differentiation.
To study the effects of Hmg20b knockdown in more depth, cytospins were prepared at different time points and stained with histological dyes and neutral benzidine (22) . The results show that by day seven after transduction, Hmg20b knockdown cells displayed increased differentiation with more than 50% hemoglobinized and enucleated cells, while only 10% of control cells were observed at these late stages of differentiation ( Figure 2D ). Direct measurement of hemoglobin content showed elevated hemoglobin levels in Hmg20b-depleted cells, further supporting the requirement of Hmg20b for renewal divisions of proerythroblasts.
To confirm that the spontaneous differentiation upon Hmg20b knockdown was not specific to the immortalized p53 null I/11 cell line, Hmg20b expression was knocked down in primary 
Hmg20b regulates Gfi1b expression during erythropoiesis
Hmg20b knockdown resulted in Gfi1b downregulation in I/11 cells ( Figure 3A) . Since it is known that the CoREST complex regulates Gfi1b expression in erythroblasts (8) Figure 3B ). In MEL and I/11 cells, Hmg20b followed a pattern of enrichment on the Gfi1b promoter similar to that of Lsd1 ( Figure 3C ). These results suggest that Hmg20b regulates Gfi1b expression in erythroid progenitors as part of the CoREST complex.
The majority of genes deregulated upon Hmg20b depletion are upregulated
To explore the changes in whole genome expression profiles of Hmg20b-depleted cells in comparison with control cells, microarray experiments were performed in biological triplicates.
RNA for expression profiling was harvested from I/11 cells three days after transduction with lentiviral shRNA vectors. Following array hybridization, we first ensured that the triplicate samples were closely correlated ( Figure 4A ). To validate the microarray data, QRT-PCR was performed for several selected target genes including upregulated genes such as Hrasls3, Trp53inp1, Cited2, Ccng2, and downregulated genes such as Rcor2 and Kit. This analysis showed a generally good correlation between the microarray expression data and QRT-PCR results on the same genes (Online Supplementary Figure 3 and Online Supplementary Table 2 ). Taking a 1.5-fold change in gene expression with p-value <0.01 as a cut off, the analysis of the microarray data showed deregulation of 620 genes, the majority of which (85%; 527 out of 620) had been upregulated (Online Supplementary Table 3 ). This strongly points at a generally repressive role of Hmg20b in erythroid gene expression. However, some of the deregulated genes (15%; 93 out of 620) were downregulated indicating that Hmg20b may have a dual role as either an activator or a repressor in erythroid cells (Figure 4 B-C).
Knockdown of Hrasls3 inhibits erythroid differentiation
We noted that the Hrasls3 tumor suppressor gene was among the upregulated genes in the Hmg20b- Figure 5G ). This considerable increase in expression was not observed in double knockdown Hmg20b / Hrasls3 cells. In these cells, the expression of εy-globin mRNA still increased to some extent, but significantly less than in Hmg20b-only depleted cells ( Figure 5G ).
Collectively, we conclude that Hrasls3 contributes positively to erythroid differentiation, and that the observed spontaneous differentiation upon Hmg20b knockdown can at least partially be attributed to increased expression levels of Hrasls3.
Discussion
The current study has elucidated Hmg20b as a repressor of terminal erythroid differentiation. To To extend our understanding on the regulatory function of Hmg20b protein, we searched for the factors that can be directly regulated by Hmg20b. Hmg20b has been purified as a subunit of the CoREST complex, mediating repression of neurogenesis through recruitment by REST protein to the RE1 sequence of the target genes (5). In erythroid cells, Gfi1b represses gene expression through recruitment of the CoREST complex to its target genes (8) . Studies on GFP-Gfi1b-knockin mice demonstrated that Gfi1b is highly expressed in mouse fetal liver cells, the anatomical site where hematopoiesis takes place at midgestation (36) . In the absence of Gfi1b, only a small fraction of erythroblasts is able to differentiate and the accumulation of immature erythrocytes is observed (36) (37) . In vitro studies demonstrated that Gfi1b knockdown impairs erythroid differentiation as well (8, 15) . Gfi1b expression is autoregulated, and it recruits the CoREST complex to its promoter (8, 38) . Proteomics analysis demonstrated association of the Hmg20b protein with the CoREST complex in erythroid cells, and we showed direct binding of Hmg20b to the Gfi1b promoter. We therefore conclude that Gfi1b-mediated CoREST recruitment to the Gfi1b promoter regulates Gfi1b expression ((8, 38) , Figure 6 ).
One of the consistently upregulated genes upon Hmg20b depletion was the Hrasls3 tumor suppressor gene. Hrasls3-overexpressing cells can not be expanded in culture, demonstrating the role of Hrasls3 in suppressing cellular proliferation (39) (40) . In fibroblasts, overexpression of Hrasls3 augments adipogenesis and accordingly Hrasls3 downregulation inhibits adipocyte differentiation (34, (41) (42) . We find that, similar to the observations in adipogenesis, Hrasls3 expression increases during erythroid differentiation. We demonstrated that shRNA-mediated downregulation of Hrasls3 inhibits erythroid differentiation. It therefore appears that Hrasls3 plays a key role in distinct differentiation processes, as exemplified by adipogenesis and erythropoiesis ( Figure 6 ). Additionally, we found that the spontaneous differentiation phenotype observed upon Hmg20b depletion is dependent on the upregulation of Hrasls3.
In conclusion, we found that Hmg20b is a repressor of erythroid differentiation. It acts in the autoregulatory loop of Gfi1b expression, helping to maintain the Gfi1b/CoREST activity that serves to repress erythroid differentiation. Upon Hmg20b knockdown the majority of differentially expressed genes are upregulated and the terminal differentiation program ensues. Furthermore, Hmg20b knockdown leads to derepression of the embryonic β -like globin genes. We discovered that Hrasls3 is an important gene repressed by Hmg20b, and that upregulation of Hrasls3 plays an important role during terminal erythroid differentiation.
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